Rhythm Pharmaceuticals, Inc.

RYTMNASDAQHealthcare● Active

$85.93

$-0.48(-0.55%)

Market Cap$5.9B

P/E Ratio—

52W High$122.2

52W Low$60.7

Avg Volume806K

Open$87.09

Beta1.92

Overview

Rhythm Pharmaceuticals, Inc.（RYTM）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · RYTM · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Rhythm Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

RYTM 季度内部人买卖趋势

RYTM 内幕交易卖出 · RYTM 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

998K499K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · RYTM CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

RYTM 高管卖出股份 · RYTM 董事内幕交易 · SEC Form 4申报

显示最近 52 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 18, 2026	Smith Hunter C CFO	Option	3,000	$17.87	$54K	119,611	Form 4
May 15, 2026	German Christopher Paul Corporate Controller & CAO	Option	1,406	$17.97	$25K	4,643	Form 4
May 15, 2026	German Christopher Paul Corporate Controller & CAO	Option	1,349	$49.23	$66K	3,237	Form 4
May 15, 2026	German Christopher Paul Corporate Controller & CAO	Option	1,687	$56.69	$96K	1,888	Form 4
May 15, 2026	German Christopher Paul Corporate Controller & CAO	Sale	4,643	$92.21	$428K	0	Form 4
Apr 1, 2026	Mazabraud Yann EVP, Head of International	Option	12,875	—	—	66,030	Form 4
Mar 12, 2026	Mathers Edward T Director	Other	4,199	—	—	14,168	Form 4
Mar 4, 2026	German Christopher Paul Corporate Controller & CAO	Option	1,500	$17.97	$27K	5,753	Form 4
Mar 4, 2026	German Christopher Paul Corporate Controller & CAO	Sale	5,614	$89.56	$503K	160	Form 4
Mar 2, 2026	Mathers Edward T Director	Other	4,198	—	—	9,969	Form 4
Mar 1, 2026	German Christopher Paul Corporate Controller & CAO	Option	1,162	—	—	4,595	Form 4
Mar 1, 2026	German Christopher Paul Corporate Controller & CAO	Other	342	$94.94	$32K	4,253	Form 4
Mar 2, 2026	Smith Hunter C CFO	Option	6,099	$6.80	$41K	116,611	Form 4
Feb 17, 2026	Smith Hunter C CFO	Sale	1,200	$99.42	$119K	117,266	Form 4
Feb 17, 2026	Smith Hunter C CFO	Sale	200	$100.52	$20K	117,066	Form 4
Feb 17, 2026	Smith Hunter C CFO	Sale	900	$101.70	$92K	116,166	Form 4
Feb 17, 2026	Smith Hunter C CFO	Sale	1,069	$103.00	$110K	115,097	Form 4
Feb 17, 2026	Smith Hunter C CFO	Sale	200	$103.84	$21K	114,897	Form 4
Feb 19, 2026	Smith Hunter C CFO	Sale	1,308	$100.27	$131K	113,589	Form 4
Feb 19, 2026	Smith Hunter C CFO	Sale	1,692	$100.92	$171K	111,897	Form 4
Feb 19, 2026	Smith Hunter C CFO	Sale	800	$102.10	$82K	111,097	Form 4
Feb 19, 2026	Smith Hunter C CFO	Sale	585	$103.28	$60K	110,512	Form 4
Feb 14, 2026	Mazabraud Yann EVP, Head of International	Option	10,000	—	—	53,155	Form 4
Feb 10, 2026	Smith Hunter C CFO	Sale	1,913	$102.66	$196K	123,624	Form 4
Feb 10, 2026	Smith Hunter C CFO	Sale	700	$103.68	$73K	122,924	Form 4

Smith Hunter C

CFO

Option

日期

May 18

股数

3,000

均价

$17.87

总金额

$54K

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Option

日期

May 15

股数

1,406

均价

$17.97

总金额

$25K

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Option

日期

May 15

股数

1,349

均价

$49.23

总金额

$66K

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Option

日期

May 15

股数

1,687

均价

$56.69

总金额

$96K

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Sale

日期

May 15

股数

4,643

均价

$92.21

总金额

$428K

View Form 4 on SEC.gov

Mazabraud Yann

EVP, Head of International

Option

日期

Apr 1

股数

12,875

均价

—

总金额

—

View Form 4 on SEC.gov

Mathers Edward T

Director

Other

日期

Mar 12

股数

4,199

均价

—

总金额

—

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Option

日期

Mar 4

股数

1,500

均价

$17.97

总金额

$27K

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Sale

日期

Mar 4

股数

5,614

均价

$89.56

总金额

$503K

View Form 4 on SEC.gov

Mathers Edward T

Director

Other

日期

Mar 2

股数

4,198

均价

—

总金额

—

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Option

日期

Mar 1

股数

1,162

均价

—

总金额

—

View Form 4 on SEC.gov

German Christopher Paul

Corporate Controller & CAO

Other

日期

Mar 1

股数

342

均价

$94.94

总金额

$32K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Option

日期

Mar 2

股数

6,099

均价

$6.80

总金额

$41K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 17

股数

1,200

均价

$99.42

总金额

$119K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 17

股数

200

均价

$100.52

总金额

$20K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 17

股数

900

均价

$101.70

总金额

$92K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 17

股数

1,069

均价

$103.00

总金额

$110K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 17

股数

200

均价

$103.84

总金额

$21K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 19

股数

1,308

均价

$100.27

总金额

$131K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 19

股数

1,692

均价

$100.92

总金额

$171K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 19

股数

800

均价

$102.10

总金额

$82K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 19

股数

585

均价

$103.28

总金额

$60K

View Form 4 on SEC.gov

Mazabraud Yann

EVP, Head of International

Option

日期

Feb 14

股数

10,000

均价

—

总金额

—

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 10

股数

1,913

均价

$102.66

总金额

$196K

View Form 4 on SEC.gov

Smith Hunter C

CFO

Sale

日期

Feb 10

股数

700

均价

$103.68

总金额

$73K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 RYTM 内幕交易

RYTM 内幕交易

Rhythm Pharmaceuticals, Inc.（RYTM）内幕交易数据来源于公司内部人（包括Smith Hunter C (CFO), German Christopher Paul (Corporate Controller & CAO), Mazabraud Yann (EVP, Head of International)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。RYTM内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Rhythm Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

RYTM 内幕交易 · 5个问题

Rhythm Pharmaceuticals, Inc.（RYTM）的内部人包括高管和董事，如Smith Hunter C (CFO), German Christopher Paul (Corporate Controller & CAO), Mazabraud Yann (EVP, Head of International)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

RYTM 董事内幕交易RYTM 内部人名单Rhythm Pharmaceuticals, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026